MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-43-0025403
Sun Rays Lifesciences Private Limited
Sun Rays Lifesciences Private Limited - pharma in Kanpur, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹61.88 Lakh
▲ 5% YoY
Net profit · FY 2024
₹9,558
Net margin 0.2%
EBITDA · FY 2024
₹2.11 Lakh
EBITDA margin 3.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹12 Lakh
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
About Sun Rays Lifesciences Private Limited
Data last updated:
Sun Rays Lifesciences Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 September 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U85191UP2011PTC046770. Its GSTIN is 09AAQCS9310L1ZO (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Aftab Ahmad and Jay Prakash Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 15/58 Friends Enclave Flat No. A – 1 Civil Lines, Kanpur, Uttar Pradesh, India – 208001.
As per the financials filed for FY 2024, the company reported a revenue of ₹61.88 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹9,558 (net margin 0.2%) and EBITDA of ₹2.11 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹12 Lakh on record.
Sun Rays Lifesciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-43-0025403). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U85191UP2011PTC046770
Registration Number 046770
Incorporation Date 28 September 2011
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-43-0025403
Key People
Aftab Ahmad Director Jay Prakash Agrawal Director Recognitions & Rankings of Sun Rays Lifesciences
Contact details
Sun Rays Lifesciences Private Limited's registered office is in Kanpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address15/58 Friends Enclave Flat No. A – 1 Civil Lines, Kanpur, Uttar Pradesh, India – 208001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sun Rays Lifesciences Private Limited, buy the company report.
Comprehensive company report
Sun Rays Lifesciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sun Rays Lifesciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sun Rays Lifesciences Private Limited, buy the company report.
Financials of Sun Rays Lifesciences Private Limited
FY 2025 filings availableSun Rays Lifesciences Private Limited reported revenue of ₹61.88 Lakh (up 5% YoY) for FY 2024.
Revenue · FY 2024
₹61.88 Lakh ▲ 5%
Net profit · FY 2024
₹9,558 margin 0.2%
EBITDA · FY 2024
₹2.11 Lakh margin 3.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 11%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 12%
3 years · compounded
▲ 5%
5 years · compounded
▲ 6%
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 5% growth in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9,558 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sun Rays Lifesciences Private Limited, buy the company report.
Board of directors of Sun Rays Lifesciences Private Limited
Sun Rays Lifesciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aftab Ahmad | Director | 28 Sep 2011 | 15 Years 0 Months | Current |
| Jay Prakash Agrawal | Director | 15 Mar 2013 | 13 Years 7 Months | Current |
Peer comparison
Sun Rays Lifesciences Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Macto Mediscience Private Limited | ₹61.93 Lakh (FY 2025) | 93.0% | Hubli, Karnataka, India | |||
| Sun Rays Lifesciences Private Limitedthis company | ₹61.88 Lakh (FY 2024) | ₹9,558 | 0.2% | 5.0% | Kanpur, Uttar Pradesh, India | |
| Flaxwin Lifesciences Private Limited | ₹61.54 Lakh (FY 2024) | 41.0% | Ahmedabad, Gujarat, India | |||
| Mezzone Healthcare Private Limited | ₹61.44 Lakh (FY 2016) | New Delhi, Delhi, India |
To see the full peer comparison of Sun Rays Lifesciences Private Limited, buy the company report.
Shareholding
The shareholding of Sun Rays Lifesciences Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Sun Rays Lifesciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹12 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Mar 2016 | 100016824 | Others | ₹12 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sun Rays Lifesciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sun Rays Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sun Rays Lifesciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAQCS9310L1ZO | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sun Rays Lifesciences Private Limited, buy the company report.
Recent activity
Sun Rays Lifesciences Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Ashwani Kumar Singh ceased to be Director on 22 Jul 2014.
AGM
Sun Rays Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sun Rays Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Charges
A charge with Others amounted to Rs. 12.00 Lakh with Charge ID 100016824 was registered on 03 Mar 2016.
Ceased
Ashwani Kumar Singh ceased to be Director.
Appointed
Jay Prakash Agrawal was appointed as Director.
Appointed
Aftab Ahmad was appointed as Director.
Incorporation
28 Sep 2011
Sun Rays Lifesciences Private Limited was registered on 28 Sep 2011 with Roc Kanpur & aged 15 years 29 days as per MCA records.
Frequently asked questions
Sun Rays Lifesciences is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 September 2011 (15+ years old) and is registered under CIN U85191UP2011PTC046770.
Sun Rays Lifesciences has 2 current directors:
- Aftab Ahmad - Director
- Jay Prakash Agrawal - Director
The latest financial statements of Sun Rays Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sun Rays Lifesciences is 09AAQCS9310L1ZO, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Sun Rays Lifesciences is U85191UP2011PTC046770. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sun Rays Lifesciences was incorporated on 28 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Sun Rays Lifesciences by revenue are Macto Mediscience Private Limited, Flaxwin Lifesciences Private Limited, Mezzone Healthcare Private Limited, all in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (wholesale trading).
Ashwani Kumar Singh ceased to be Director on 22 Jul 2014. Jay Prakash Agrawal was appointed as Director on 15 Mar 2013. Aftab Ahmad was appointed as Director on 28 Sep 2011.
Yes, Sun Rays Lifesciences is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-43-0025403).
The registered office of Sun Rays Lifesciences is at 1558 Friends Enclave Flat No. A – 1 Civil Lines, Kanpur, Uttar Pradesh, India – 208001.
Sun Rays Lifesciences operates in the pharma industry, in the drug formulation and development segment.